National Institute for Health and Care Excellence. (2014). Dyspepsia: investigation and management (CG17). National Clinical Guideline Centre.
Chey, W. D., Leontiadis, G. I., Howden, C. W., & Moss, S. F. (2017). ACG clinical guideline: treatment of Helicobacter pylori infection. The American Journal of Gastroenterology, 112(2), 212-239.
Malfertheiner, P., Megraud, F., O'Morain, C. A., Atherton, J., Axon, A. T., Bazzoli, F., … & European Helicobacter and Microbiota Study Group. (2017). Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report. Gut, 66(1), 6-30.
Targownik, L. E., Leslie, W. D., Davison, K. S., & Lix, L. M. (2012). Long-term use of proton pump inhibitors and risk of hip fracture: a population-based cohort study. Gastroenterology, 143(3), 619-626.
Jackson, J. L., O'Malley, P. G., Tomkins, G., Balden, E., Santoro, J., & Kroenke, K. (2000). Treatment of dyspepsia with antidepressants: a meta-analysis. The American Journal of Medicine, 108(1), 65-72.
Chey, W. D., Wong, B. C. Y., & Practice Parameters Committee of the American College of Gastroenterology. (2007). American College of Gastroenterology guideline on the management of Helicobacter pylori infection. The American Journal of Gastroenterology, 102(8), 1808-1825.